Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101)

Akihiko Shimomura; Kenji Tamura; Kiyo Tanaka; Tomonori Mizutani; Keita Sasaki; Yuta Sekino; Masataka Sawaki; Tadahiko Shien; Taro Shibata; Hiroji Iwata

doi:10.1093/jjco/hyab124

Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101)

Akihiko Shimomura, Kenji Tamura, Kiyo Tanaka, Tomonori Mizutani, Keita Sasaki, Yuta Sekino, Masataka Sawaki, Tadahiko Shien, Taro Shibata, Hiroji Iwata

University Hospital

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the originally published version of this manuscript, the title and a citation was incorrect. In the title, the spelling of the author group was incorrect. It should read “Japan Clinical Oncology Group Study”, instead of, “Japan Clinical Oncollgy Group Study”. The author of reference number 3 was incorrect. It should read “Ministry of Health, Labour and Welfare", instead of, "Ministry of Health Law”. These errors have been corrected online.

Original language	English
Pages (from-to)	1479
Number of pages	1
Journal	Japanese journal of clinical oncology
Volume	51
Issue number	9
DOIs	https://doi.org/10.1093/jjco/hyab124
Publication status	Published - Sept 1 2021

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jjco/hyab124

Fingerprint

Dive into the research topics of 'Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101)'. Together they form a unique fingerprint.

Cite this

Shimomura, A., Tamura, K., Tanaka, K., Mizutani, T., Sasaki, K., Sekino, Y., Sawaki, M., Shien, T., Shibata, T., & Iwata, H. (2021). Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101). Japanese journal of clinical oncology, 51(9), 1479. https://doi.org/10.1093/jjco/hyab124

Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101). / Shimomura, Akihiko; Tamura, Kenji; Tanaka, Kiyo et al.
In: Japanese journal of clinical oncology, Vol. 51, No. 9, 01.09.2021, p. 1479.

Research output: Contribution to journal › Comment/debate › peer-review

Shimomura, A, Tamura, K, Tanaka, K, Mizutani, T, Sasaki, K, Sekino, Y, Sawaki, M, Shien, T, Shibata, T & Iwata, H 2021, 'Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101)', Japanese journal of clinical oncology, vol. 51, no. 9, pp. 1479. https://doi.org/10.1093/jjco/hyab124

Shimomura A, Tamura K, Tanaka K, Mizutani T, Sasaki K, Sekino Y et al. Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101). Japanese journal of clinical oncology. 2021 Sept 1;51(9):1479. doi: 10.1093/jjco/hyab124

Shimomura, Akihiko ; Tamura, Kenji ; Tanaka, Kiyo et al. / Erratum : A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101). In: Japanese journal of clinical oncology. 2021 ; Vol. 51, No. 9. pp. 1479.

@article{d0c1b37c1fa84151a12a9c86926e2ca2,

title = "Erratum: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101)",

abstract = "In the originally published version of this manuscript, the title and a citation was incorrect. In the title, the spelling of the author group was incorrect. It should read “Japan Clinical Oncology Group Study”, instead of, “Japan Clinical Oncollgy Group Study”. The author of reference number 3 was incorrect. It should read “Ministry of Health, Labour and Welfare{"}, instead of, {"}Ministry of Health Law”. These errors have been corrected online.",

author = "Akihiko Shimomura and Kenji Tamura and Kiyo Tanaka and Tomonori Mizutani and Keita Sasaki and Yuta Sekino and Masataka Sawaki and Tadahiko Shien and Taro Shibata and Hiroji Iwata",

year = "2021",

month = sep,

day = "1",

doi = "10.1093/jjco/hyab124",

language = "English",

volume = "51",

pages = "1479",

journal = "Japanese Journal of Clinical Oncology",

issn = "0368-2811",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Erratum

T2 - A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study) (Japanese Journal of Clinical Oncology DOI: 10.1093/jjco/hyab101)

AU - Shimomura, Akihiko

AU - Tamura, Kenji

AU - Tanaka, Kiyo

AU - Mizutani, Tomonori

AU - Sasaki, Keita

AU - Sekino, Yuta

AU - Sawaki, Masataka

AU - Shien, Tadahiko

AU - Shibata, Taro

AU - Iwata, Hiroji

PY - 2021/9/1

Y1 - 2021/9/1

N2 - In the originally published version of this manuscript, the title and a citation was incorrect. In the title, the spelling of the author group was incorrect. It should read “Japan Clinical Oncology Group Study”, instead of, “Japan Clinical Oncollgy Group Study”. The author of reference number 3 was incorrect. It should read “Ministry of Health, Labour and Welfare", instead of, "Ministry of Health Law”. These errors have been corrected online.

AB - In the originally published version of this manuscript, the title and a citation was incorrect. In the title, the spelling of the author group was incorrect. It should read “Japan Clinical Oncology Group Study”, instead of, “Japan Clinical Oncollgy Group Study”. The author of reference number 3 was incorrect. It should read “Ministry of Health, Labour and Welfare", instead of, "Ministry of Health Law”. These errors have been corrected online.

UR - http://www.scopus.com/inward/record.url?scp=85115907629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115907629&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyab124

DO - 10.1093/jjco/hyab124

M3 - Comment/debate

C2 - 34296283

AN - SCOPUS:85115907629

SN - 0368-2811

VL - 51

SP - 1479

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

IS - 9

ER -